IRVINE, CA, Oct 18, 2011 (MARKETWIRE via COMTEX) --

ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced it will release third quarter 2011 financial results after the market closes on November 1, 2011. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time to review the Company's commercial operations and provide pipeline updates.

Date: Tuesday, November 1, 2011 Time: 4:30 p.m. Eastern Time

Conference call access: Internet: www.istavision. Domestic dial-in: 866.825.1692 International dial-in: 617.213.8059 Passcode: 90996630

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888.286.8010; international participants may dial 617.801.6888. The access code for the replay is 93234261. This conference call will be webcast live and archived on ISTA's website until December 2, 2011.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals, Inc. is a fast growing and the third largest branded prescription eye care business in the United States with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at www.istavision.com. 

Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302
lsilvernail@istavision.
Jeanie Herbert
949-789-3159
jherbert@istavision.
Media and Additional Investor Relations Contacts at Burns McClellan:
Justin Jackson
(Media)
212-213-0006
jjackson@burnsmc.
Juliane Snowden
(Investor Relations)
212-213-0006
jsnowden@burnsmc.

SOURCE: ISTA Pharmaceuticals 

mailto:lsilvernail@istavision.mailto:jherbert@istavision.mailto:jjackson@burnsmc.mailto:jsnowden@burnsmc.